
The Cleartest SARS-CoV-2 / Influenza A+B / RSV Antigen Combo Rapid Test is a chromatographic in vitro diagnostic test for the qualitative detection of SARS-CoV-2 nucleocapsid protein, influenza A and B antigens, and RSV antigens from nasopharyngeal swabs. It is used for the rapid differential diagnosis of acute respiratory infections with overlapping symptoms.
The test enables the simultaneous detection of four relevant respiratory pathogens in a single procedure. Results are available within approximately 15 minutes, facilitating timely diagnostic assessment in clinical practice. The test requires no additional equipment and is designed for standardized application.
The antigen combo test is intended for use in doctors' offices, hospitals, emergency rooms, nursing homes, testing centers, and in communal and workplace settings. It is suitable for acute diagnostics during the infection phase and supports medical professionals in structured assessment and infection control.
Storage is possible at temperatures between 2°C and 30°C. The test is intended exclusively for professional use and not for self-testing.
Delivery information:
WEEE number:
Assistive device number:
Manufacturer:
Servoprax GmbH
Am Marienbusch 9
46485 Wesel